Risk of reverse seroconversion of hepatitis B virus surface antigen in rituximab-treated non-Hodgkin lymphoma patients: A large cohort retrospective study
Liang Tsai Hsiao, Tzeon Jye Chiou, Jyh Pyng Gau, Ching Fen Yang, Yuan Bin Yu, Chun Yu Liu, Jin Hwang Liu, Po Min Chen, Cheng Hwai Tzeng, Yu Jiun Chan, Muh Hwa Yang, Yi Hsiang Huang, Chun Xia Cao
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'Risk of reverse seroconversion of hepatitis B virus surface antigen in rituximab-treated non-Hodgkin lymphoma patients: A large cohort retrospective study'. Together they form a unique fingerprint.